Condition 1: HIV/AIDS. Condition 2: Pregnancy, childbirth and the puerperium. Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases Delivery by caesarean section, unspecified
Conditions
Interventions
Intervention 1: Intervention group: In this method, healthy and motile uninfected sperm cells are isolated from other cells. Semen samples will be loaded on a sperm washing medium gradient and then ce
Prevention
Intervention group: In this method, healthy and motile uninfected sperm cells are isolated from other cells. Semen samples will be loaded on a sperm washing medium gradient and then centrifuged. Final
Control group: This study is a single arm clinical trial that has no control group.
Sponsors
Resaerch Deputy of Tehran University of Medical Sciences
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Inclusion criteria: Being Married; Men who living with HIV-1; The consent of both spouses; Uninfected women. Exclusion criteria: Lack of consent; Serum Viral load of over 500 RNA copy number/ ml.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mother infection status. Timepoint: Before the first-trimester, second-trimester and third-trimester of pregnancy. Method of measurement: Laboratory tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Minoo Mohraz
Iranian research Center for HIV AIDS (IRCHA)
Outcome results
None listed